The role of NMR-based circulating metabolic biomarkers in development and risk prediction of new onset type 2 diabetes. (2022)
Attributed to:
China Kadoorie Biobank (CKB)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-022-19159-8
PubMed Identifier: 36064959
Publication URI: http://europepmc.org/abstract/MED/36064959
Type: Journal Article/Review
Volume: 12
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322